Atossa Therapeutics, Inc. (ATOS) earnings
Quarterly results of Atossa Therapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Atossa Therapeutics, Inc. was expected to report around November 11, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Atossa Therapeutics, Inc. reported revenue of - and a net loss of $8.5M.
Diluted earnings per share were -$0.95.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | - | - | -$8.5M | -$0.95 |
| Q1 FY2026 | - | - | -$9.6M | -$1.11 |
| Q4 FY2025 | - | - | -$10.9M | - |
| Q3 FY2025 | - | - | -$8.7M | -$0.07 |
| Q2 FY2025 | - | - | -$8.4M | -$0.98 |
| Q1 FY2025 | - | - | -$6.7M | -$0.78 |
| Q4 FY2024 | - | - | -$6.3M | - |
| Q3 FY2024 | - | - | -$7.2M | -$0.06 |
Results filings
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly report 10-Q
- Annual report 10-K
- Quarterly results 8-K
When is Atossa Therapeutics, Inc.'s next earnings date?
Atossa Therapeutics, Inc. was expected to report around November 11, 2026; nothing is on file with the SEC yet.
Get an email when ATOS reports
Follow ATOS and we email you its next results the day they are filed, with the numbers explained.